Alexion, Stealth announce agreement for option to co-develop and commercialise late-stage therapy for mitochondrial diseases

Image: Alexion and Stealth to co-develop and commercialise late-stage therapy for mitochondrial diseases. Photo: courtesy of moritz320 from Pixabay.